renal

A Mother’s Gift of Life: Successful Living-Donor Kidney Transplant Restores Hope for 32 Years old Young CKD Patient from Bangladesh

HYDERABAD, India, Nov. 24, 2025 /PRNewswire/ -- In an inspiring story of resilience, medical excellence, and a mother's unconditional love,…

2 weeks ago

HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress

The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies…

2 months ago

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13)…

6 months ago